View full meeting coverage »

Eyetube Meeting Coverage:

2018 ARVO Annual Meeting


Editorially Independent Content, Financially Supported by


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Real-World Outcomes of nAMD Treated With Anti-VEGF Therapy

  Channels: Retina | Posted 5/3/2018

Thomas A. Ciulla, MD, details a study that examined change of visual acuity versus frequency of anti-VEGF injections over 1 year in patients with neovascular age-related macular degeneration (nAMD). Dr. Ciulla points out key lessons that this study demonstrates.

Anti-VEGF • Neovascular Age-Related Macular Degeneration

13 / 13 Series: 2018 ARVO Annual Meeting